Subtotal: ₹2,382
Robocard P5
₹1,750
Robocard P5 is indicated for the management of the signs of mild, moderate, or severe (modified NYHA Class IIa, IIIb, or IVc) congestive heart failure in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM).
Estimated Delivery Date: April 25, 2025
No more offers for this product!
Robocard P5
While the original Robocard variant contains both Pimobendan (5 mg) and Benazepril (10 mg) in each tablet, this Robocard P5 variant contains only Pimobendan (5 mg). It is intended for dogs and puppies who have been prescribed Pimobendan only and not the ACE inhibitor Benazepril. Pimobendan is an inotropic (heart stimulant) substance that increases the strength of heart muscle contractions and opens up blood vessels carrying blood to and from the heart, thereby reducing the heart’s workload.
Features:
Robocard P5 is indicated for the management of mild, moderate, or severe congestive heart failure in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM).
(Classified under modified NYHA Class IIa, IIIb, or IVc.)
Pimobendan increases the strength of heart contractions and dilates blood vessels, reducing the heart’s workload.
Benazepril is a prodrug that is converted into Benazeprilat in the body. Benazeprilat is an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors lower the production of angiotensin II, a vasoconstrictor (a substance that narrows blood vessels).
By lowering angiotensin II production, blood vessels relax and widen, allowing blood pressure to drop and reducing the heart’s workload.
Both Pimobendan and Benazepril are already authorized as separate medicines for dogs.
Direction of Use
Use as prescribed by the doctor.
Precautions
N/A
General Inquiries
There are no inquiries yet.
Robocard P5
₹1,750
Home 
Whishlist 
Compare 
Checkout 
Account
Reviews
There are no reviews yet.